Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, September 20, 2023
[ Wed, Sep 20th 2023
] - WOPRAI
[ Wed, Sep 20th 2023
] - WOPRAI
[ Wed, Sep 20th 2023
] - WOPRAI
[ Wed, Sep 20th 2023
] - WOPRAI
[ Wed, Sep 20th 2023
] - WOPRAI
[ Wed, Sep 20th 2023
] - WOPRAI
[ Wed, Sep 20th 2023
] - WOPRAI
[ Wed, Sep 20th 2023
] - WOPRAI
[ Wed, Sep 20th 2023
] - WOPRAI
[ Wed, Sep 20th 2023
] - WOPRAI
[ Wed, Sep 20th 2023
] - WOPRAI
[ Wed, Sep 20th 2023
] - WOPRAI
[ Wed, Sep 20th 2023
] - WOPRAI
[ Wed, Sep 20th 2023
] - WOPRAI
[ Wed, Sep 20th 2023
] - WOPRAI
[ Wed, Sep 20th 2023
] - WOPRAI
[ Wed, Sep 20th 2023
] - WOPRAI
[ Wed, Sep 20th 2023
] - WOPRAI
[ Wed, Sep 20th 2023
] - WOPRAI
[ Wed, Sep 20th 2023
] - WOPRAI
[ Wed, Sep 20th 2023
] - WOPRAI
[ Wed, Sep 20th 2023
] - WOPRAI
[ Wed, Sep 20th 2023
] - WOPRAI
[ Wed, Sep 20th 2023
] - WOPRAI
Joon Lee Maintained (TSHA) at Strong Buy with Decreased Target to $5 on, Sep 20th, 2023
Joon Lee of Truist Securities, Maintained "Taysha Gene Therapies, Inc." (TSHA) at Strong Buy with Decreased Target from $6 to $5 on, Sep 20th, 2023.
Joon has made no other calls on TSHA in the last 4 months.
There are 4 other peers that have a rating on TSHA. Out of the 4 peers that are also analyzing TSHA, 0 agree with Joon's Rating of Hold.
These are the ratings of the 4 analyists that currently disagree with Joon
- Geulah Livshits of "Chardan Capital" Reiterated at Strong Buy and Held Target at $5 on, Tuesday, August 15th, 2023
- Jack Allen of "Baird" Maintained at Buy with Increased Target to $8 on, Tuesday, August 15th, 2023
- Silvan Tuerkcan of "JMP Securities" Reiterated at Buy and Held Target at $4 on, Tuesday, August 15th, 2023
- Kristen Kluska of "Cantor Fitzgerald" Maintained at Buy with Increased Target to $7 on, Monday, August 14th, 2023
